8-K: Heliogen Extends Stockholder Rights Plan and Withdraws NYSE Delisting Appeal

Sentiment:

Corporate Action Announcement


Heliogen has extended its stockholder rights plan and withdrawn its appeal against delisting from the NYSE, moving to the OTCQX market.

Worse than expectedThe company's stock has been delisted from the NYSE, which is generally considered a negative event for a company's valuation and investor confidence.

Summary

  • Heliogen has amended its stockholder rights plan, extending its expiration date by one year to April 17, 2025.
  • The exercise price of the rights has been reduced from $122.50 to $26.40.
  • The company has withdrawn its appeal against delisting from the New York Stock Exchange (NYSE).
  • Heliogen's common stock and warrants now trade on the OTCQX market under the symbols HLGN and HLGNW, respectively.
  • The company intends to continue complying with SEC regulations and other NYSE listing requirements, despite the delisting.
  • The rights plan is designed to prevent any person or group from gaining control of Heliogen without paying an appropriate premium to all stockholders.
  • The plan is not in response to a specific takeover threat and does not prevent the board from engaging with parties or accepting an acquisition proposal.
  • The rights become exercisable if a person or group acquires 12.5% or more of the company's outstanding common stock (20% for certain passive institutional investors).
  • Stockholders with beneficial ownership above the threshold at the time of the announcement are grandfathered at their current levels but cannot increase ownership without triggering the plan.

Sentiment

Score: 4

Explanation: The document contains both positive and negative elements. The extension of the rights plan and the reduction of the exercise price are positive for existing shareholders, but the delisting from the NYSE is a significant negative. The overall sentiment is slightly negative due to the delisting.

Positives

  • The extension of the Rights Plan aims to enable all stockholders to realize the long-term value of their investment.
  • The Rights Plan is intended to reduce the likelihood of a hostile takeover without an appropriate control premium.
  • The company intends to continue complying with public company SEC regulations and other NYSE listing requirements, despite the delisting.
  • The Rights Plan does not prevent the Board from engaging with parties or accepting an acquisition proposal if it is in the best interests of Heliogen and all of its stockholders.

Negatives

  • The company's stock has been delisted from the NYSE.
  • The company's stock is now trading on the over-the-counter market, which may have lower liquidity and visibility.
  • The company has experienced a significant and ongoing dislocation in the trading price of its common stock.

Risks

  • The delisting from the NYSE could negatively impact the company's stock price and investor confidence.
  • The company's stock may experience lower liquidity and visibility on the OTCQX market.
  • The company's financial and business performance is subject to uncertainty.
  • The company's ability to execute its business model and achieve market acceptance of its products and services is not guaranteed.

Future Outlook

The company is considering strategic alternatives and aims to enable all stockholders to realize the long-term value of their investment. The Rights Plan is intended to provide the Board with sufficient time to make informed judgments and take actions that are in the best interests of all stockholders.

Management Comments

  • Julie Kane, Chair of the Board, stated Heliogen continues to experience a significant and ongoing dislocation in the trading price of its common stock.
  • The extension of the Rights Plan is intended to enable all of our stockholders to realize the long-term value of their investment, particularly in light of the Company's previously announced consideration of strategic alternatives.
  • The Rights Plan should reduce the likelihood that any person or group gains control of Heliogen through open market accumulation without paying all stockholders an appropriate control premium or without providing the Board sufficient time to make informed judgments and take actions that are in the best interests of all stockholders.

Industry Context

The adoption of a stockholder rights plan is a common tactic used by publicly held companies to protect themselves from hostile takeovers, particularly when they believe their stock price is undervalued. The delisting from the NYSE and move to the OTCQX market is a significant change that may impact investor perception and trading liquidity.

Comparison to Industry Standards

  • The Rights Plan is similar to other plans adopted by publicly held companies in comparable circumstances.
  • The plan does not contain any dead-hand, slow-hand, no-hand or similar feature that limits the ability of a future Board to redeem the rights, which is consistent with best practices in corporate governance.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Rights Agreement AmendmentThe Rights Agreement was amended to extend the expiration date to April 17, 2025, and reduce the exercise price to $26.40.April 16, 2024The amendment aims to protect shareholders from hostile takeovers and ensure they receive fair value for their shares.

Stakeholder Impact

  • Shareholders may experience a change in the trading venue of their shares from the NYSE to the OTCQX market.
  • Shareholders are protected from potential hostile takeovers by the extended rights plan.
  • Employees may be impacted by the company's strategic decisions and financial performance.
  • Customers and suppliers may be impacted by the company's strategic decisions and financial performance.

Next Steps

  • The NYSE is expected to file a Notification of Removal From Listing and/or Registration with the SEC.
  • Heliogen will continue to comply with public company SEC regulations and other NYSE listing requirements.
  • The company will continue to consider strategic alternatives.

Key Dates

DateDescription
April 16, 2023Original date of the Rights Agreement.
November 7, 2023Heliogen received a delisting notice from the NYSE.
November 8, 2023Heliogen's stock began trading on the over-the-counter market.
February 15, 2024Date of a previous 8-K filing disclosing a limited waiver to Nant Capital, LLC.
March 26, 2024Heliogen's Annual Report on Form 10-K for the year ended December 31, 2023 was filed with the SEC.
April 15, 2024Heliogen notified the NYSE of its intention to withdraw its delisting appeal.
April 16, 2024Heliogen entered into Amendment No. 1 to the Rights Agreement and issued a press release.
April 17, 2025New expiration date of the Rights Agreement.

Keywords

stockholder rights plan, delisting, NYSE, OTCQX, rights agreement, takeover, acquisition, corporate governance, shareholder value, Heliogen

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.